Autoantibody negativity and autoimmune hepatitis severity
Treatments studied
Part of Digestive system clinical trials.
This trial checks if the absence of certain antibodies in autoimmune hepatitis (AIH) is linked to more severe disease. It may help doctors better understand and treat AIH.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have autoimmune hepatitis (AIH) and are being treated with medications that suppress your immune system
- You are being followed at Hôpital Saint-Antoine or in Guadeloupe as part of a specific liver disease network
- You are covered by French social security
- You can give written consent to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information and blood samples from people with autoimmune hepatitis and other liver conditions to better understand these diseases. Taking part may help with research, though it is not a treatment trial.
This study looks at fats (lipids) in the blood of people with autoimmune hepatitis to find patterns that might help diagnose or monitor the disease. It may lead to better ways to manage the condition.
This study looks at what factors affect how well the liver responds to treatment in people with autoimmune hepatitis. It may help doctors understand why some people respond better than others and could lead to more personalized care.
This study follows people with autoimmune hepatitis (a condition where the immune system attacks the liver) and requires key blood test results at diagnosis. It may help doctors better understand this disease and how it progresses in patients in China.
This study is testing a new way to predict how well steroid treatment will work for people with severe autoimmune hepatitis, a condition where the immune system attacks the liver. If you qualify, the findings may help doctors personalize your care and improve outcomes.
This study is building a database and collection of samples from people with autoimmune hepatitis in Italy. It aims to learn more about the disease and improve care.
Hear when a new Auto-immune Hepatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.